Trial Profile
Clinical Trials Insight: 700022826
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2007
Price :
$35
*
At a glance
- Drugs Mapatumumab (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Human Genome Sciences
- 02 May 2007 New trial record.